alexa Forearm Mass in Rheumatoid Arthritis: Infection or Malignancy | OMICS International
ISSN: 2161-1149
Rheumatology: Current Research

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Forearm Mass in Rheumatoid Arthritis: Infection or Malignancy

Norah A. Musallam1, Shehanah F. AlOmair1 and Mohammed A. Omair2*

1College of Medicine, King Saud University, Riyadh, Saudi Arabia

2Rheumatology Department, Collage of Medicine, King Saud University, Riyadh, Saudi Arabia

*Corresponding Author:
Mohammed A. Omair
College of Medicine
King Saud University
Riyadh, Saudi Arabia
Tel: 966505270513
E-mail: [email protected]

Received date: August 01, 2016; Accepted date: August 02, 2016 Published date: August 05, 2016

Citation: Musallam NA, AlOmair FS, Omair MA, (2016) Forearm Mass in Rheumatoid Arthritis: Infection or Malignancy. Rheumatology (Sunnyvale) 6:203. doi:10.4172/2161-1149.1000203

Copyright: © 2016 Musallam NA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Rheumatology: Current Research


Rheumatoid arthritis; Tuberculosis; Infection; Methotrexate; Immunosuppression

Case Presentation

A 60-year old Saudi Caucasian female with a 10-year history of Rheumatoid Arthritis and Diabetes Mellitus, treated with prednisolone 5 mg daily, MTX 15 mg weekly and etanercept 50 mg weekly, presented with a swelling in the volar aspect of the right forearm just below the cubitus fossa for 2 months duration. The swelling was preceded by generalized pain in the whole right upper limb that limited her movement for one week. There was no history of recent trauma, respiratory symptoms, fever, weight loss, night sweats or loss of appetite. Patient denied any history of prior tuberculosis (TB) or a close contact with a TB patient. PPD prior to initiation of Etanercept was negative. Clinical examination showed a solitary, skin colored, stony, hard, non-tender non-pulsatile, fixed nodule with irregular borders measuring about 7 × 10 cm. The overlying skin had no signs of redness, dilated veins, sinus or scars. MRI of the right elbow illustrated multinucleated collection involving the subcutaneous area with insinuation between muscle fibers with a possible connection to the joint space. Erosive changes within the elbow were present with no signs of osteomyelitis.

Ultrasound guided true cut biopsy was performed and histopathological examination showed necrotizing granulomatous inflammation with positive Ziehl–Neelsen stain for acid fast bacilli, consistent with mycobacterial infection with no evidence of coexisting malignant cells.

CT chest-abdomen-pelvis revealed multiple pulmonary and hilar nodules; the largest measuring 1.5 × 2.4 cm. CT abdomen: Liver was mildly enlarged with a homogenous enhancement with no focal lesion.

Etanercept was discontinued, patient was started a 4 drug regimen: isoniazid, rifampin, pyrazinamide, and ethambutol for 2 months then kept on isoniazid and rifampin for a total duration of 9 months. After 3 months of treatment, the mass regressed significantly. At 6 months, Etanercept was resumed with almost complete resolution of the mass and good tolerability to therapy.


Conflict of Interest

The authors have no conflict of interest.

Financial Disclosure

The authors declare no financial interest, and the case report was not funded by any external funding agency.

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 8901
  • [From(publication date):
    specialissue-2016 - Jul 21, 2018]
  • Breakdown by view type
  • HTML page views : 8773
  • PDF downloads : 128

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7